Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis
暂无分享,去创建一个
A. Wynshaw-Boris | P. Hurlin | S. Ota | Zi-Qiang Zhou | K. Toyo-oka | S. Hirotsune | William L. Walker | Zi‐Qiang Zhou | Sara Ota
[1] B. Edgar,et al. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. , 2003, Genes & development.
[2] Jean Y. J. Wang,et al. Coordinated regulation of life and death by RB , 2003, Nature Reviews Cancer.
[3] Stella Pelengaris,et al. c-MYC: more than just a matter of life and death , 2002, Nature Reviews Cancer.
[4] A. Menssen,et al. Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[5] Mark J. Murphy,et al. c-Myc regulates mammalian body size by controlling cell number but not cell size , 2001, Nature.
[6] P. Hurlin,et al. The interplay between Mad and Myc in proliferation and differentiation. , 2001, Trends in cell biology.
[7] Charles J. Sherr,et al. The INK4a/ARF network in tumour suppression , 2001, Nature Reviews Molecular Cell Biology.
[8] F. Alt,et al. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. , 2001, Immunity.
[9] John N. Hutchinson,et al. Transgenic mouse models of human breast cancer , 2000, Oncogene.
[10] Myles Brown,et al. Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription , 2000, Cell.
[11] A. Poustka,et al. Physical and transcriptional mapping of the 17p13.3 region that is frequently deleted in human cancer. , 2000, Genomics.
[12] P. Farnham,et al. Direct Examination of Histone Acetylation on Myc Target Genes Using Chromatin Immunoprecipitation* , 2000, The Journal of Biological Chemistry.
[13] J F Barrett,et al. Identification of CDK4 as a target of c-MYC. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[14] R. Eisenman,et al. The Myc/Max/Mad network and the transcriptional control of cell behavior. , 2000, Annual review of cell and developmental biology.
[15] T. Möröy,et al. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc , 1999, Oncogene.
[16] N. Jenkins,et al. Mga, a dual‐specificity transcription factor that interacts with Max and contains a T‐domain DNA‐binding motif , 1999, The EMBO journal.
[17] John M. Sedivy,et al. c-Myc Regulates Cyclin D-Cdk4 and -Cdk6 Activity but Affects Cell Cycle Progression at Multiple Independent Points , 1999, Molecular and Cellular Biology.
[18] J L Cleveland,et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.
[19] N. Dyson. The regulation of E2F by pRB-family proteins. , 1998, Genes & development.
[20] D. Ledbetter,et al. The human ROX gene: genomic structure and mutation analysis in human breast tumors. , 1998, Genomics.
[21] R. Eisenman,et al. Sequential expression of the MAD family of transcriptional repressors during differentiation and development , 1998, Oncogene.
[22] B. Amati,et al. Myc and the cell cycle. , 1998, Frontiers in bioscience : a journal and virtual library.
[23] Richard A. Ashmun,et al. Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF , 1997, Cell.
[24] L. Hennighausen,et al. Cre-mediated gene deletion in the mammary gland. , 1997, Nucleic acids research.
[25] D. Ledbetter,et al. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non‐canonical E box and acts as a transcriptional repressor , 1997, The EMBO journal.
[26] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[27] R. Eisenman,et al. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. , 1997, Genes & development.
[28] F. Alt,et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[29] F. Zindy,et al. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest , 1995, Cell.
[30] N. Copeland,et al. Mad3 and Mad4: novel Max‐interacting transcriptional repressors that suppress c‐myc dependent transformation and are expressed during neural and epidermal differentiation. , 1995, The EMBO journal.
[31] M. J. van de Vijver,et al. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. , 1994, Cancer research.
[32] S. Lowe,et al. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. , 1993, Genes & development.
[33] Gerard I. Evan,et al. Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.
[34] J. Cleveland,et al. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.
[35] L. Penn,et al. C-MYC: evidence for multiple regulatory functions. , 1990, Seminars in cancer biology.
[36] R. Weinberg,et al. Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts , 1986, Molecular and cellular biology.
[37] H. Green,et al. QUANTITATIVE STUDIES OF THE GROWTH OF MOUSE EMBRYO CELLS IN CULTURE AND THEIR DEVELOPMENT INTO ESTABLISHED LINES , 1963, The Journal of cell biology.